Jeffrey Thomas Jensen MD

Obstetrics & Gynecology•Portland, OR

Professor, Obstetrics & Gynecology, Oregon Health and Science University School of Medicine

Join to View Full Profile

3181 Sw Sam Jackson Park RdDept Ob/Gyn, Uhn-70, OhsuPortland, OR 97239
Phone+1 503-494-4469
Fax+1 503-494-5083

Education & Training

Oregon Health & Science University (OHSU Health)Residency, Obstetrics and Gynecology, 1985 - 1988
Santa Clara Valley Medical CenterInternship, Transitional Year, 1984 - 1985
Emory University School of MedicineClass of 1984

Certifications & Licensure

OR State Medical License 1985 - 2025
WA State Medical License 2023 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

A Study of Continuous Oral Contraceptives and Doxycycline Start of enrollment: 2007 May 01
Completed
Not Applicable
Hormonal Contraception and Vaginal Health Start of enrollment: 2007 May 01
Completed
Not Applicable
Relationship Between the Menstrual Cycle and Heart Disease in Women Start of enrollment: 2012 Feb 01
Completed
Not Applicable
Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days Start of enrollment: 2014 Mar 01
Completed
Phase 2
HSG and Tubal Patency Study Start of enrollment: 2014 May 01
Completed
Not Applicable
Immediate Postplacental IUD Insertion Start of enrollment: 2014 Sep 01
Terminated
Not Applicable
Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods Start of enrollment: 2015 Sep 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Effects of estetrol/drospirenone on Self-Reported Physical and Emotional Premenstrual and Menstrual Symptoms: Data from the Phase 3 Clinical Trial in the United States...
Céline Bouchard, Johannes Bitzer, Melissa J Chen, Jeffrey T Jensen, Andrew M Kaunitz
Contraception. 2025-03-20
1 citations
Use of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter c...
Jeffrey T Jensen, Alison Edelman, Carolyn L Westhoff, Coutney A Schreiber, David F Archer
Contraception. 2024-09-01
4 citations
Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel.
Alison Edelman, Jeffrey T Jensen, Jill Brown, Michael Thomas, David F Archer
Contraception. 2024-09-01

Lectures

Contraceptive Technology
Contemporary Forums, Boston, Massachusetts - 3/28/2012
Contraceptive Technology
Contemporary Forums, San Francisco, California - 3/7/2012

Press Mentions

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy DesignationOctober 24th, 2024
Bayer's Removal of Contraceptive Device Essure Praised by ActivistsJuly 27th, 2018

Grant Support

A low-profile copper intrauterine device that delivers long-acting contraception anUNIVERSITY OF WASHINGTON2020–2025
Transcervical Polidocanol Foam As Nonsurgical Female Sterilization TechniqueNational Center For Research Resources2011
Phosphodiesterase 3 Inhibitors: Blockers Of Oocyte Maturation And FertilizationNational Center For Research Resources2007–2011
PDE3 Inhibitors: Selective Blockers Of Oocyte MaturationEunice Kennedy Shriver National Institute Of Child Health &Human Development2004–2007
Phosphodiesterase 3 Inhibitors: Selective Blockers Of Oocyte Maturation And FertNational Center For Research Resources2005–2006
Transcervical Polidocanol As A Non-Surgical Method Of Female SterilizationNational Center For Research Resources2004

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow